| HOME >> BIOLOGY >> TECHNOLOGY |
“SynCardia already serves 30 of the top transplant centers in the world, with an additional 22 centers currently undergoing SynCardia certification training. The Freedom portable driver has provided us with the opportunity to train additional transplant centers in the U.S., Europe and Australia/New Zealand.”
Prior to joining TandemHeart, Mr. Garippa served as CEO and President of Gateway HomeCare. In addition, Mr. Garippa was Founder and CEO of Millennium HomeCare and The Prompt Care Companies. His background also includes being National Sales Manager at Omni Medical and Senior Analyst with the NYC Health and Hospitals Corporation. Mr. Garippa has a master’s degree from New York University and a Bachelor of Arts degree from Rutgers University.
*Through the IDE clinical study, stable Total Artificial Heart patients who meet study criteria may have the option to be discharged from the hospital with the Freedom portable driver, to wait for their matching donor heart at home and in their communities.
###
About SynCardia Systems, Inc.
SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artificial Heart. There have been more than 850 implants of the Total Artificial Heart, accounting for more than 190 patient years of life on the device.
Originally used as a permanent replacement heart, the Total Artificial Heart is currently approved as a bridge to human heart transplant for people dying from end-stage biventricular failure. The Tota
'/>"/>
| Source: PRWeb Copyright©2010 Vocus, Inc. All rights reserved |